| Date | Time | Source | Headline | Symbol | Company |
| 06/03/2012 | 21:00 | Business Wire | Allos Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/03/2012 | 21:11 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/03/2012 | 23:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/03/2012 | 23:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/03/2012 | 23:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/03/2012 | 23:15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/03/2012 | 23:14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/03/2012 | 23:14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/03/2012 | 23:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 27/02/2012 | 22:48 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 27/02/2012 | 22:47 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 27/02/2012 | 22:45 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 27/02/2012 | 22:44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 27/02/2012 | 22:44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 27/02/2012 | 22:43 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 27/02/2012 | 22:42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 27/02/2012 | 22:41 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 24/02/2012 | 11:13 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 23/02/2012 | 23:19 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 21/02/2012 | 13:00 | Business Wire | Allos Therapeutics to Report Fourth Quarter and Full Year 2011 Results on March 6, 2012 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 14/02/2012 | 20:33 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 14/02/2012 | 17:04 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 14/02/2012 | 15:43 | Edgar (US Regulatory) | Schedule 13G | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/02/2012 | 15:59 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/02/2012 | 17:46 | Zacks | ALTH Seeks Review of Folotyn Verdict - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 31/01/2012 | 22:18 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 30/01/2012 | 13:30 | Business Wire | Allos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at the European Medicines Agency | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 30/01/2012 | 13:00 | Business Wire | Allos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTYN® & Bexarotene Demonstrate Activity in... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 23/01/2012 | 12:00 | Zacks | European Setback for Allos - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 20/01/2012 | 12:49 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |